VIDEO HUB

Hear a comprehensive overview of entX’s strategy, highlighting how our core capability in radioisotope sourcing, processing and purification underpins three high-growth sectors: healthcare, space, and defence from our Managing Director, Bryn Jones.

This video explains how IsoMedica is addressing the global shortage of radioisotopes and why building a scalable, secure supply chain is critical for the future of radiopharmaceuticals. Radiopharmaceuticals are among the fastest-growing therapeutic modalities in oncology, supporting around 40 million procedures annually.

Persistent, reliable power remains one of the greatest challenges facing modern Defence and space capability. This webinar outlines how entX is developing next generation betavoltaic power technology through its GenX platform to address this growing capability gap.

In this Space and Defense webinar, Scott Edwards explores one of the most persistent challenges in lunar exploration: surviving the lunar night. The entX Radioisotope Heating Unit (RHU) is engineered specifically to help solve this challenge.

IsoMedica is addressing the growing need for reliable alpha isotope supply through vertical integration, scalable production and established commercial relationships. entX is building a differentiated medical isotope platform focused on sovereign capability and execution.

As entX transitions from technology development into commercial execution, through the commissioning of the ARMF, securing supply pathways, and expanding production capabilities, IsoMedica is building the foundations to support future radiopharmaceutical innovation.

entX is progressing towards flight heritage through a US-based suborbital launch with payload recovery, while undertaking the nuclear flight safety process with a leading US National Laboratory, an assessment traditionally reserved for government-led missions.

Building an advanced radioisotope manufacturing facility requires specialised hot cells, major capital investment, complex regulatory approvals and a skilled workforce with expertise in radiation safety and compliant manufacturing.

How does GenX move from technology development to real-world applications? In this snippet Scott explains how entX is progressing GenX through prototype manufacturing and product validation.

How do you prove the commercial value of the entX Radioisotope Heating Unit (RHU)? In this snippet, Scott Edwards explains how entX is working with lunar lander companies and payload developers, to assess how the RHU can support missions through the lunar night.

Often referred to as "nuclear batteries", betavoltaics are more accurately described as compact nuclear generators capable of producing reliable power for years or decades, when paired with the right radioisotope. Traditionally, betavoltaics have been limited to extremely low power outputs.

GenX is a thin-film composite betavoltaic power platform developed by entX to deliver high power density and unlock new applications for long-duration power. From the beginning, GenX has been designed with manufacturing scalability in mind, leveraging processes already used in high-volume industries.

In this episode Scott explains how GenX is redefining the potential of betavoltaic technology. Often referred to as a "nuclear battery", betavoltaics are more accurately described as small nuclear generators. When paired with the right radioisotope, they can provide reliable power for years, potentially decades, without the need for recharging.

How do you prove a technology designed to survive the harsh conditions of the Moon?  In this episode, we explain how entX is validating its Radioisotope Heating Unit (RHU) through a 3U lunar payload demonstrator incorporating the RHU, thermal switch and thermal management system.

This episode explores how our approach to isotope selection and system design sets the RHU apart from conventional solutions. Rather than relying on plutonium-based systems, which are scarce, highly regulated, and inaccessible, we use isotopes sourced from established nuclear medicine supply chains.

One of the most fundamental challenges in lunar exploration is surviving the lunar night. In this episode of the entX Technology Insights Series: RHU, we explore the Radioisotope Heating Unit (RHU) a technology designed to enable survival in extreme lunar environments.

How does IsoMedica produce the radioisotopes that support next generation cancer therapies?  In this snippet of the entX Technology Insights Series, Chief Scientific Officer, Massey de los Reyes explains the three-step process behind IsoMedica's integrated production platform.

Our advantage is vertical integration.  Few companies globally can bring together the science, infrastructure and supply model needed to support the growing radiopharmaceutical market. Even fewer can do it in one place.  At entX, our competitive moat is built on three key pillars.

Radiopharmaceuticals are one of the fastest-growing areas in precision oncology. As demand for these therapies continues to grow, access to reliable, high-purity radioisotopes remains a major challenge.  In this episode Massey explains why IsoMedica exists and why building a sovereign, secure and reliable supply chain is critical to supporting the future of nuclear medicine.

What does it take to turn complex nuclear science into real-world healthcare solutions?  In this clip Massey de los Reyes explains how entX is building a scalable, customer-focused medical isotope platform supported by expertise across nuclear science, engineering, manufacturing and automation.